“The Russian market already more than 60 years is key for “Gedeon Richter”. In 1996 the company took the decision to build in Russia own manufacture in Moscow region Egorevsk. Today, the company “Gedeon Richter-Rus” is able to offer you in Russia a full cycle of production of high-quality and affordable drugs”, — stated in the message.
MOSCOW, December 11./strong>. Pharmaceutical company “Gedeon Richter” was the winner of the National award “Priority 2015” in the special nomination for achievements in the localization business in the Russian market, according to a press release from the company.
“The Russian market already more than 60 years is key for “Gedeon Richter”. In 1996 the company took the decision to build in Russia own manufacture in Moscow region Egorevsk. Today, the company “Gedeon Richter-Rus” is able to offer you in Russia a full cycle of production of high-quality and affordable drugs”, — stated in the message.
In 2010 the company took the decision to participate in the implementation of the strategy of the Ministry of industry and trade of the Russian Federation’s “Pharma 2020” that aims by 2020 to 80% to provide the market with the drugs made in Russia. By this time, “Gedeon Richter-Rus” is planning to substitute imports of drugs manufactured outside the Russian Federation, the products of own production. To this end we expanded the production capacity of the company in Russia — completed in 2015.
“Since the beginning of 2000-ies in the creation and development of the plant the company has invested more than $ 100 million. However, we plan if necessary to attract additional investments to produce in Russia demanded the whole range of products of the company” — presented in a press release, the words of the General Director of the “Gedeon Richter-Rus” Zsolt Helmetsi.
